Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (511-520 of 567) with videos related to

Pageof 57
Sort By:
American Heart Journal|August 31, 2000
Negative T waves shortly after ST-elevation acute myocardial infarction are a powerful marker for improved survival rateE B Sgarbossa, P M Meyer, S L Pinski, et al.
Circulation|May 16, 2002
Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigationL A Szczech, P J Best, E Crowley, et al.
Stroke|March 20, 1998
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesJ M Gebel, C A Sila, M A Sloan, et al.
Journal of the American College of Cardiology|July 14, 2001
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization NetworkP Kaul, Y Fu, W C Chang, et al.
The Annals of Thoracic Surgery|September 2, 2000
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTingA M Lincoff, L A LeNarz, G J Despotis, et al.
The American Journal of Cardiology|November 13, 2001
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study)J E Tcheng, J D Talley, J C O'Shea, et al.
JAMA|March 3, 1999
Prognostic value of the admission electrocardiogram in acute coronary syndromesS Savonitto, D Ardissino, C B Granger, et al.
Journal of the American College of Cardiology|February 6, 1999
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-IIB E Tardiff, R M Califf, J E Tcheng, et al.
American Heart Journal|June 30, 2001
Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experienceC F Lundergan, A M Ross, W F McCarthy, et al.
American Heart Journal|June 1, 1997
Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive modelC M O'Connor, W R Hathaway, E R Bates, et al.
Pageof 57

Showing results (511-520 of 567) with videos related to

Sort By:
Pageof 57
American Heart Journal|August 31, 2000
Negative T waves shortly after ST-elevation acute myocardial infarction are a powerful marker for improved survival rateE B Sgarbossa, P M Meyer, S L Pinski, et al.
Circulation|May 16, 2002
Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigationL A Szczech, P J Best, E Crowley, et al.
Stroke|March 20, 1998
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesJ M Gebel, C A Sila, M A Sloan, et al.
Journal of the American College of Cardiology|July 14, 2001
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization NetworkP Kaul, Y Fu, W C Chang, et al.
The Annals of Thoracic Surgery|September 2, 2000
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTingA M Lincoff, L A LeNarz, G J Despotis, et al.
The American Journal of Cardiology|November 13, 2001
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study)J E Tcheng, J D Talley, J C O'Shea, et al.
JAMA|March 3, 1999
Prognostic value of the admission electrocardiogram in acute coronary syndromesS Savonitto, D Ardissino, C B Granger, et al.
Journal of the American College of Cardiology|February 6, 1999
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-IIB E Tardiff, R M Califf, J E Tcheng, et al.
American Heart Journal|June 30, 2001
Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experienceC F Lundergan, A M Ross, W F McCarthy, et al.
American Heart Journal|June 1, 1997
Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive modelC M O'Connor, W R Hathaway, E R Bates, et al.
Pageof 57